|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ezetimibe protently inhibits cholestrol absorption but does not affect hepatic or intestinal cholestrol synthesis in rats显示文摘 | M van Heek C Farley DS Compton | 2003 | Br J Parmacol2003，138，8： | 1 |
| 2 | Neuropeptide Y receptors as targets for anti-obesity drug development:perspective and current status 显示文摘 | Parker E Van Heek M Stamford A | 2002 | Eur J Pharmacol2002，440，： | 1 |
| 3 | Aspects of coal properties and constitution important for gasification显示文摘 | VAN HEEK K H M(U)HLEN H-J | 1985 | Fuel1985，64，10： | 1 |
| 4 | Comparison of the activity and disposition of the novel cholesterol absorption inhibitor,SCH58235,and its glucuronide,SCH60663显示文摘 | Van Heek M Farley C Compton DS | 2000 | Br J Pharmacol2000，129，： | 1 |
| 5 | The cholesterol ab- sorption inhibitor, ezetimibe, decreases diet-induced hy- percholesterolemia in monkeys 显示文摘 | van Heek M Compton DS Davis HR | 2001 | Eur J Pharmacol2001，415，1： | 1 |
| 6 | Aspects of coal properties and constitution important for gasification显示文摘 | VAN HEEK K H HEINE-JURGEN M | 1985 | Fuel1985，64，10： | 1 |
| 7 | In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor,SCH5825,in the rat and rhesus monkey through the identification of the active metabolites of SCH48461显示文摘 | van Heek M France CF Compton DS | | 0，，： | 1 |
| 8 | Neuropeptide Y receptors as targets for anti-obesity drug development:perspective and current status显示文摘 | Parker E Van Heek M Stamford A | | 0，，2： | 1 |
| 9 | Neuropeptide Y receptors as targets for anti-obesity drug development:perspective and current status显示文摘 | PARKER E VAN HEEK M STARNFORD A | 2002 | European Journal of Pharmacology2002，440，23： | 1 |
| 10 | Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats 显示文摘 | Farley C Compton DS | 2003 | Br J Pharmacol2003，138，8： | 1 |
| 11 | The cholesterolabsorption inhibitor, ezetimibe, decreases diet-inducedhypercholesterolemia in monkeys 显示文摘 | van Heek M Compton DS Davis HR | 2001 | Eur J Pharmacol2001，415，1： | 1 |
| 12 | In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor,SCH 58235,in the rat and rhesus monkey through identification of the active metabolites of SCH 48461显示文摘 | Van Heek M France C F Compton D S | 1997 | J Pharm Exper Ther1997，283，1： | 1 |
| 13 | Diet-induced obese mice Develop peripheral, but not centra, lresistance to leptin 显示文摘 | Van Heek M Compton D France C | 1997 | J Clin Invest1997，99，3： | 1 |
| 14 | Ezetimibe selectively inhibits intestinal cholesterol absorption in ro- dents in the presence and absence of exocrine pancreatic function 显示文摘 | van Heek M Fadey C Compton DS Hoos L Davis HR | 2001 | BrJ Pharmacol2001，134，2： | 1 |
| 15 | Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663显示文摘 | van HEEK M FARLEY C COMPTON DS | 2000 | Br J Pharmacol2000，129，8： | 1 |
| 16 | Diet-induced obese mice develop peripheral, but not central, resistance to leptin 显示文摘 | Van Heek M Compton DS France CF | 1997 | J Clin Invest1997，99，1： | 1 |
| 17 | Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function显示文摘 | Van Heek M Farley C Compton DS | 2001 | Br J Clin Phamacol2001，134，2： | 1 |
| 18 | Diet-induced obese mice develop peripheral, but not central, resistance to leptin显示文摘 | Van Heek M Compton DS France CF | 1997 | J Clin Invest1997，99，3： | 1 |
| 19 | Aspects of coal properties and constitution important for gasification显示文摘 | Van Heek K H Mühlen H J | 1985 | Fuel1985，64，： | 1 |
| 20 | In vivo mechanism-based discovery of a potent cholesterol absorption inhibitor(SCH58235)through the identification of the active metabolites of SCH48461显示文摘 | Van Heek M France C F Compton D S | 1997 | J Pharmacol Exp Ther1997，283，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员